Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
With GLP-1 (glucagon-like peptide-1 receptor agonists) medications, there are now more options available for people looking to help manage their weight and related health conditions
Understanding these potential changes is essential for accurate interpretation of test results and appropriate clinical decision-making
This is slightly below the industry average of 68% for GLP-1 weight-loss medications across all payers (Zepbound, Wegovy, Saxenda combined) reported by IQVIA in 2024
This pricing reflects competitive positioning rather than production cost differences
It is what you would expect when you remove something the body had adapted around
For example, someone using GLP1 drugs without medical advice might not recognize early signs of pancreatitis or other complications, which can become life-threatening if untreated
